학술논문
IDF23-0498 Subgroup analysis of Phase 3 study of dapagliflozin, glimepiride and metformin ER FDC in T2DM patients with HbA1c 9%–11%
Document Type
Abstract
Author
Source
In Diabetes Research and Clinical Practice March 2024 209 Supplement 1
Subject
Language
ISSN
0168-8227